ENDPOINTS

#AACR25: Keytruda around head and neck cancer surgery cuts chance of disease coming back

Merck’s widely used cancer drug Keytruda could soon be getting another indication — this time for use before and after surgery for head and neck cancer. On Sunday, data presented from the pivotal trial showed adding ...

Apr 28, 2025 - 08:07
 0
#AACR25: Keytruda around head and neck cancer surgery cuts chance of disease coming back
Merck’s widely used cancer drug Keytruda could soon be getting another indication — this time for use before and after surgery for head and neck cancer. On Sunday, data presented from the pivotal trial showed adding ...
Read More

Tags:

Previous Article

Hello freedom fans! Ian the climate denialist potato is back – the REAL enemy is...

Next Article

#AACR25: Revolution’s KRAS drug shows potential in early cut of lung cancer data

Related Posts

Preventive health startup Superpower raises $30M

Preventive health startup Superpower raises $30M

Apr 22, 2025  0

Updated: Roche’s $50B US investment includes previous build announcements

Updated: Roche’s $50B US investment includes previous b...

Apr 22, 2025  0

Lotte Bio launches ADC services; Ypsomed to focus on self-injection business

Lotte Bio launches ADC services; Ypsomed to focus on se...

Apr 24, 2025  0